The intranasal Covid vaccine to be introduced in the COVID-19 vaccination program from today
The Centre on Friday approved Bharat Biotech‘s needle-free intranasal Covid vaccine for a booster dose, said an official source. The nasal vaccine will likely be added to the CoWIN App from this day only.
The nasal vaccine has been approved for those aged above 18 years. The vaccine will be available in private hospitals for booster doses in the initial phase.
The source said the nasal vaccine will be used as a heterologous booster among the eligible population. Meanwhile, the source also expects the intranasal Covid vaccine to be introduced in the COVID-19 vaccination program from Friday.
Meanwhile, India on Friday reported 163 fresh COVID-19 cases along with nine deaths have also been reported in the country. The number of active Coronavirus cases declined to 3,380.
China is currently seeing a surge in COVID-19 cases and is imposing forced lockdowns. Meanwhile, India proacts and gears up to fight a potential resurgence of the Covid virus.
[With Inputs from IANS]
PGurus is now on Telegram. Click here to join our channel and stay updated with all the latest news and views
For all the latest updates, download PGurus App.
- IIT Delhi shows game-changing technologies to German Defence Minister - June 7, 2023
- Adani Group shows record-breaking performance across portfolios; EBITDA grows at 36% to Rs.57,219 cr - June 7, 2023
- Partnership with India one of the most consequential, says US principal deputy spokesperson - June 7, 2023
Export to Taiwan. Let Chinese citizens believing Indian vaccine effectiveness to take jabs in Taiwan and those Chinese will spread Indian message within China
Can we export Indian vaccines to China as part of Vasudev Kutumb ?